Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-25 of 30 for your search:
Start Over
Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
Phase: Phase IV
Type: Treatment
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: LAL-07OLD, NCT01366898
The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 40 and over
Sponsor: Other
Protocol IDs: ASAPOL, NCT01549418
Gefitinib Combined With Thalidomide to Treat NSCLC
Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: Over 18 to less than 75
Sponsor: Other
Protocol IDs: GELI, NCT02387086
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000577892, SINGAPORE-ICR-02, SINGAPORE-ASCOLT, SINGAPORE-07-32-LGI, ICR-02, NCT00565708
The Effect Of Aspirin On Survival in Lung Cancer
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 2010-018360-16, NCT01058902
Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GCO 09-1300-00002, P01CA108671, MPD-RC 112, NCT01259856
Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols
Phase: Phase III
Type: Prevention
Status: Approved-not yet active
Age: 40 to 60
Sponsor: Other
Protocol IDs: CREAT, NCT01496521
The International Polycap Study 3 (TIPS-3)
Phase: Phase III
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: TIPS-3, NCT01646437
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LC-ASPIRIN, ASPIRIN-13-08, NCT01936233
Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: D-13-01, 2013-004269-15, NCT02125409
A Trial of Aspirin on Recurrence and Survival in Elderly Colon Cancer Patients
Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: P14.152, NCT02301286
Low-dose Aspirin Therapy for Esophageal Cancer
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: NNSFC 81302455, NCT02326779
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: UCI 07-47, NCT00578721
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580
First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: VICC BMT 1020, NCT01215344
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GCO 09-1300 001, P01CA108671, MPD-RC 111, NCT01259817
Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-MM-PI-0345, NCT01380106
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: CH-BC-011, NCT01431053
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-01006, N01-CN-2012-00031, HHSN2612012000311, 1300000502, UAZ2013-01-01, N01CN00031, P30CA023074, NCT02123849
Aspirin for Lung Cancer
Phase: Phase II
Type: Prevention
Status: Approved-not yet active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: 2013-0732, HHSN261201200034I, NCT02135497
Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: ASPIDIA, NCT02323516
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2015-00061, 1403269898, HHSN2612012000311, UAZ2013-02-01, N01CN00031, P30CA023074, NCT02348203
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 081501, NCI-2015-00397, P30CA072720, NCT02420652
Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: V1010, NCT01612247
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: VICC THN 1227, NCI-2012-01800, P50CA090949, NCT01707823
Start Over